The Loss of Exclusivity Planning Course for Pharma
With Dr Neal Hansen & James Kettlewell
Course Details
THE CONTENT
With over $180 billion in pharmaceutical company revenues expected to lose exclusivity before 2030, some of the largest brands in the industry will face significant late-lifecycle challenges in the coming years. Yet there is still limited understanding of what Loss of Exclusivity (LOE) really means among pharma professionals — and, more importantly, an underappreciation of the opportunities to continue delivering sustainable value for patients even in the face of generic or biosimilar competition.
This course provides a practical approach to understanding and preparing for LOE, rooted in real-life industry case studies & tangible examples of effective (and ineffective) LOE planning. You will learn how to anticipate the likely impact of LOE, understand the diversity in how post-LOE dynamics evolve across global markets, and be introduced to the processes, frameworks, and tools that enable the effective navigation of LOE events.
If you want to ensure that your brand is adequately prepared for the challenges and opportunities posed by LOE, this course is a must-attend!
I highly recommend this masterclass! The structure and facilitation were excellent. The content was practical and beautifully packaged, using real-world examples that clearly demonstrated the relevance of each strategy. It also fostered highly valuable discussion among the participants. This is the ideal course for companies looking to get up to speed with their late lifecycle management planning activities.
MSD
Till Bauer, Global Oncology LCM Strategy Director - Germany - June 2026
THE EXPERTS
Dr Neal Hansen is a dynamic and engaging speaker. You will leave his course inspired and equipped with actionable insights!
Founder and CEO of Align Strategy, an international pharma consultancy with over 25 years of experience in advising the pharma industry on LLC management & navigating LOE events.
Co-author of Pharmaceutical Lifecycle Management – Making the Most of Each and Every Brand (Wiley & Sons, 2012), and a long-standing CELforPharma faculty member who has always been highly rated by participants for his vast experience and teaching style.
Joining Neal will be James Kettlewell:
A Principal Consultant at Align Strategy with over a decade of experience supporting global pharmaceutical and biotech companies in addressing their key strategic challenges.
James has extensive experience in supporting clients planning for LOE, through the development and implementation of planning frameworks and tools, and he brings deep knowledge of the post-LOE dynamics of a diverse range of global markets.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma professionals with responsibility for lifecycle-management planning at the global, regional or local levels, across a wide range of functions including commercial, marketing, medical, access, and clinical. It is particularly valuable for those working with brands expecting to face generic or biosimilar competition within the next 7-8 years — the earlier LOE planning begins, the more opportunities can be realised.
Through a mix of expert-led teaching and interactive exercises, you will learn the key principles that determine when Loss of Exclusivity (LOE) occurs and how it affects a brand. You will also be introduced to practical frameworks and tools that support strong LOE planning. The course format includes real-life case studies, structured group exercises and peer discussions. These activities are designed to help you build the practical skills needed to prepare for LOE and to execute effective plans.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
What LOE means and the factors that determine both its timing and its impact.
How and why markets can behave very differently after generics or biosimilars enter, both across countries and within a single market.
The proven processes and frameworks that support effective, cross-functional LOE planning at the global, regional, and local levels, and that ensure buy-in at every stage.
The toolkit of tactical options available for late-lifecycle planning, illustrated with real-world case studies, and how to judge which options are most relevant for your brand.
The critical success factors for building strong LOE plans that support your brand through and beyond the entry of generics and biosimilars.
Just completed CELforPharma’s Loss of Exclusivity Planning Course — an outstanding and highly practical deep dive into late-lifecycle management. The PSVA framework, market archetypes, and real-world case studies make this course a must for anyone involved in pharma commercial strategy. I’m walking away with a clear, actionable playbook. Highly recommended!
Gilead Sciences
Nicolas Salvador, Associate Director, Business Analytics and SFE - Benelux - June 2026
| Welcome & Introductions (~15 min) |
| Loss of Exclusivity Basics: The Fundamentals of Biosimilar & Generic Entry (~45 min) |
|
| Demystifying Local Post-Loss of Exclusivity Dynamics (~1 h 15 min) |
|
| The Blueprint for Loss of Exclusivity Success (~45 min) |
|
| Lunch Break |
| The Essential Loss of Exclusivity Planning Toolkit (~1 h) |
|
| Loss of Exclusivity Planning in Action (~1 h 15 min) |
|
| Loss of Exclusivity Planning Excellence: Validating & Stress-Testing Your Plan (~45 min) |
|
| Wrap-Up and Key Takeaways (~15 min) |
UPCOMING DATES & FORMATS - FEES
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
I highly recommend this masterclass! The structure and facilitation were excellent. The content was practical and beautifully packaged, using real-world examples that clearly demonstrated the relevance of each strategy. It also fostered highly valuable discussion among the participants. This is the ideal course for companies looking to get up to speed with their late lifecycle management planning activities.
MSD
Till Bauer, Global Oncology LCM Strategy Director - Germany - June 2026
The LOE Course provided several valuable insights. First, it gave me a clearer understanding of the LOE planning process and its key steps, creating a solid foundation for developing a structured LOE. Second, it reinforced the importance of bringing leadership on board early, ensuring alignment, sponsorship, and successful execution. Third, it highlighted that an LOE plan is fundamentally different from a brand plan. While both are equally important, an effective LOE requires its own dedicated process, framework, and capabilities to drive long-term organisational excellence and sustainable impact. A key takeaway from this course is that optimising mature brands can be a game changer. With the right approach to LOE planning, organisations can continue to create value and maximise the potential of brands throughout their lifecycle.
BIAL
Carmen Proença, Senior Global Marketing & Capabilities Excellence Manager - Portugal - June 2026
Just completed CELforPharma’s Loss of Exclusivity Planning Course — an outstanding and highly practical deep dive into late-lifecycle management. The PSVA framework, market archetypes, and real-world case studies make this course a must for anyone involved in pharma commercial strategy. I’m walking away with a clear, actionable playbook. Highly recommended!
Gilead Sciences
Nicolas Salvador, Associate Director, Business Analytics and SFE - Benelux - June 2026
Real experts share their knowledge in a way that you can immediately apply in your own practice.
Bristol-Myers Squibb
Daan Camphijn, Therapeutic Area Lead Established Brands & Hospital Access Lead - Belgium/Luxembourg - June 2026
This was an excellent training course. There was a good mix of presentations, discussions, and breakout sessions to put the learning into practice.
BIAL
Ed Scott, Senior Manager Marketing Excellence - Portugal - June 2026
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis or call +32 473 65 15 77.
Course Details
Dates & Locations
Upcoming Session
17 November 2026, Live online
Early bird € 1 570
(until 16/10/2026)
(Full fee € 1 770)
Prices are excl. VAT
THE CONTENT
With over $180 billion in pharmaceutical company revenues expected to lose exclusivity before 2030, some of the largest brands in the industry will face significant late-lifecycle challenges in the coming years. Yet there is still limited understanding of what Loss of Exclusivity (LOE) really means among pharma professionals — and, more importantly, an underappreciation of the opportunities to continue delivering sustainable value for patients even in the face of generic or biosimilar competition.
This course provides a practical approach to understanding and preparing for LOE, rooted in real-life industry case studies & tangible examples of effective (and ineffective) LOE planning. You will learn how to anticipate the likely impact of LOE, understand the diversity in how post-LOE dynamics evolve across global markets, and be introduced to the processes, frameworks, and tools that enable the effective navigation of LOE events.
If you want to ensure that your brand is adequately prepared for the challenges and opportunities posed by LOE, this course is a must-attend!
I highly recommend this masterclass! The structure and facilitation were excellent. The content was practical and beautifully packaged, using real-world examples that clearly demonstrated the relevance of each strategy. It also fostered highly valuable discussion among the participants. This is the ideal course for companies looking to get up to speed with their late lifecycle management planning activities.
MSD
Till Bauer, Global Oncology LCM Strategy Director - Germany - June 2026
THE EXPERTS
Dr Neal Hansen is a dynamic and engaging speaker. You will leave his course inspired and equipped with actionable insights!
Founder and CEO of Align Strategy, an international pharma consultancy with over 25 years of experience in advising the pharma industry on LLC management & navigating LOE events.
Co-author of Pharmaceutical Lifecycle Management – Making the Most of Each and Every Brand (Wiley & Sons, 2012), and a long-standing CELforPharma faculty member who has always been highly rated by participants for his vast experience and teaching style.
Joining Neal will be James Kettlewell:
A Principal Consultant at Align Strategy with over a decade of experience supporting global pharmaceutical and biotech companies in addressing their key strategic challenges.
James has extensive experience in supporting clients planning for LOE, through the development and implementation of planning frameworks and tools, and he brings deep knowledge of the post-LOE dynamics of a diverse range of global markets.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma professionals with responsibility for lifecycle-management planning at the global, regional or local levels, across a wide range of functions including commercial, marketing, medical, access, and clinical. It is particularly valuable for those working with brands expecting to face generic or biosimilar competition within the next 7-8 years — the earlier LOE planning begins, the more opportunities can be realised.
Through a mix of expert-led teaching and interactive exercises, you will learn the key principles that determine when Loss of Exclusivity (LOE) occurs and how it affects a brand. You will also be introduced to practical frameworks and tools that support strong LOE planning. The course format includes real-life case studies, structured group exercises and peer discussions. These activities are designed to help you build the practical skills needed to prepare for LOE and to execute effective plans.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
What LOE means and the factors that determine both its timing and its impact.
How and why markets can behave very differently after generics or biosimilars enter, both across countries and within a single market.
The proven processes and frameworks that support effective, cross-functional LOE planning at the global, regional, and local levels, and that ensure buy-in at every stage.
The toolkit of tactical options available for late-lifecycle planning, illustrated with real-world case studies, and how to judge which options are most relevant for your brand.
The critical success factors for building strong LOE plans that support your brand through and beyond the entry of generics and biosimilars.
Just completed CELforPharma’s Loss of Exclusivity Planning Course — an outstanding and highly practical deep dive into late-lifecycle management. The PSVA framework, market archetypes, and real-world case studies make this course a must for anyone involved in pharma commercial strategy. I’m walking away with a clear, actionable playbook. Highly recommended!
Gilead Sciences
Nicolas Salvador, Associate Director, Business Analytics and SFE - Benelux - June 2026
| Welcome & Introductions (~15 min) |
| Loss of Exclusivity Basics: The Fundamentals of Biosimilar & Generic Entry (~45 min) |
|
| Demystifying Local Post-Loss of Exclusivity Dynamics (~1 h 15 min) |
|
| The Blueprint for Loss of Exclusivity Success (~45 min) |
|
| Lunch Break |
| The Essential Loss of Exclusivity Planning Toolkit (~1 h) |
|
| Loss of Exclusivity Planning in Action (~1 h 15 min) |
|
| Loss of Exclusivity Planning Excellence: Validating & Stress-Testing Your Plan (~45 min) |
|
| Wrap-Up and Key Takeaways (~15 min) |
UPCOMING DATES & FORMATS - FEES
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
I highly recommend this masterclass! The structure and facilitation were excellent. The content was practical and beautifully packaged, using real-world examples that clearly demonstrated the relevance of each strategy. It also fostered highly valuable discussion among the participants. This is the ideal course for companies looking to get up to speed with their late lifecycle management planning activities.
MSD
Till Bauer, Global Oncology LCM Strategy Director - Germany - June 2026
The LOE Course provided several valuable insights. First, it gave me a clearer understanding of the LOE planning process and its key steps, creating a solid foundation for developing a structured LOE. Second, it reinforced the importance of bringing leadership on board early, ensuring alignment, sponsorship, and successful execution. Third, it highlighted that an LOE plan is fundamentally different from a brand plan. While both are equally important, an effective LOE requires its own dedicated process, framework, and capabilities to drive long-term organisational excellence and sustainable impact. A key takeaway from this course is that optimising mature brands can be a game changer. With the right approach to LOE planning, organisations can continue to create value and maximise the potential of brands throughout their lifecycle.
BIAL
Carmen Proença, Senior Global Marketing & Capabilities Excellence Manager - Portugal - June 2026
Just completed CELforPharma’s Loss of Exclusivity Planning Course — an outstanding and highly practical deep dive into late-lifecycle management. The PSVA framework, market archetypes, and real-world case studies make this course a must for anyone involved in pharma commercial strategy. I’m walking away with a clear, actionable playbook. Highly recommended!
Gilead Sciences
Nicolas Salvador, Associate Director, Business Analytics and SFE - Benelux - June 2026
Real experts share their knowledge in a way that you can immediately apply in your own practice.
Bristol-Myers Squibb
Daan Camphijn, Therapeutic Area Lead Established Brands & Hospital Access Lead - Belgium/Luxembourg - June 2026
This was an excellent training course. There was a good mix of presentations, discussions, and breakout sessions to put the learning into practice.
BIAL
Ed Scott, Senior Manager Marketing Excellence - Portugal - June 2026
People attending this course are typically also interested in the below courses.
Need help to find the right course? Email Inge Cornelis or call +32 473 65 15 77.